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Summary 
BACKGROUND: Population based studies show a steady 
increase in adult patients with congenital heart defects. 
The aim of this study was to assess the evolution of such 
a patient cohort and its burden on clinical care at a ded-
icated tertiary care centre. 
METHODS: All patients with congenital heart disease fol-
lowed up by a dedicated multidisciplinary team at our 
institution were identified (n = 1725). Disease character-
istics, the increase in patient numbers and interventions 
and the increase in selected complications were ana-
lysed and compared between the first (1996–2005) and 
second (2006–2015) decades of the study period. 
RESULTS: Between the two decades of the study period, 
the number of patients in follow-up increased by 109%, 
the number of patients who died or underwent trans-
plantation more than doubled and the number of out-
patient visits increased by 195%. One fourth of all pa-
tients underwent at least one surgical procedure and 
14% had at least one percutaneous intervention. The in-
crease in surgical procedures between the two decades 
was 27% and the increase in percutaneous interventions 
159%. Between the two decades the number of patients 
requiring direct current cardioversion increased from 32 
to 95 (+197%), the number of patients requiring admis-
sion for infective endocarditis increased from 7 to 29 
(+314%) and the number of women followed up during 
pregnancy increased from 18 to 115 (+539%). 
CONCLUSION: As a result of the increasing number and 
complexity of adult survivors with congenital heart dis-
ease more resources will be needed to cope with the de-
mands of this novel cohort of complex patients in adult 
cardiology. 
Key words: congenital heart disease; adult congenital 
heart disease; epidemiology; resources 
Background 
Congenital heart defects are the most common birth 
defects, affecting about 1% of newborns [1–3]. 
Only a few decades ago the majority of affected pa-
tients with complex defects died in early childhood 
[1]. This has changed dramatically with the inven-
tion of open-heart surgery and improved cardiology 
care. In the contemporary era, about 90% of affected 
children are expected to survive to adulthood [4]. 
This has led to rapidly increasing new cohorts of 
adult survivors with congenital heart disease [5]. 
These adults are not cured and many remain at high 
risk of cardiovascular complications [6, 7]. Patients 
with defects of moderate or great disease complex-
ity are at particularly increased risk of premature 
death as young adults [8]. Specialist care of adults 
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with congenital heart disease in multidisciplinary 
tertiary care centres has been shown to improve out-
comes and is thus recommended by international 
guidelines [9–13]. The impact of increasing patient 
numbers and recommended specialist care of these 
patients on the workload at specialised tertiary care 
centres has not been well studied. Such data may be 
important to help healthcare authorities and hospital 
administrations to allocate appropriate resources to 
cope with the needs of this novel group of complex 
patients in adult cardiology. 
The aims of this study were, therefore, to describe 
the evolution of cohorts of adults with congenital 
heart disease at a single tertiary care centre over a 
20-year period and to analyse the impact of increas-
ing patient numbers on the workload of specialist 
care teams. 
Methods 
Patient cohorts 
All patients who had been followed up by a dedi-
cated team of specialists for adult congenital heart 
disease at a single tertiary care centre between 1996 
and 2015 were identified from the clinical database. 
The evolution of patient numbers and the character-
istics of the heart defects were reported. Defects 
were classified in accordance with previously pub-
lished disease classification; simple defects, defects 
of moderate complexity and defects of great com-
plexity were distinguished [1]. Patients with Marfan 
syndrome and related disorders, as well as selected 
patients with noncongenital heart disease followed 
up by the dedicated team of specialists in congenital 
heart disease (mainly pregnant women with ac-
quired heart disease), were also included into the 
study cohort as they contributed to the increasing 
workload. The rationale for including pregnant 
women with acquired heart disease was the fact that 
at most centres care for these patients is provided by 
the dedicated congenital heart disease teams. 
Within this patient cohort we analysed the number 
of surgical and interventional procedures that were 
performed at our institution during the study period. 
As surrogates for the complexity of patient care, we 
analysed the number of patients requiring direct cur-
rent cardioversion and the number of patients re-
quiring admission for infective endocarditis. Fur-
thermore, we reported the increasing number of 
women who were followed up during pregnancy, as 
their care increases the overall in- and outpatient 
workload substantially. 
Changes in patient numbers or numbers of proce-
dures over time are reported either as changes from 
the first to the second decade of the study period 
(1996–2005 vs 2006–2015), or as changes between 
5-year periods (1996–2000, 2001–2005, 2006–2010 
and 2011–2015) as more appropriate and illustrative 
for individual characteristics. 
The study was approved by the local ethics board. 
Statistics 
Continuous data are presented as mean ± standard 
deviation or median with range as appropriate. Cat-
egorical data are presented as number with percent-
age. For comparison between groups, chi squared 
tests, Fisher’s exact test, Student’s t-test or the 
Mann-Whitney test was used, as appropriate. Two-
sided p-values <0.05 were considered statistically 
significant. 
Results 
Patient cohorts 
A total of 2045 patients with congenital heart dis-
ease were identified from our administrative data-
base. We excluded 250 patients who were followed 
up by general cardiologists not specialised in adult 
congenital heart disease. These patients had mainly 
simple defects (73%), particularly isolated aortic 
valve disease (41%), or small or repaired shunt le-
sions (24%). We also excluded 70 patients who 
were referred for surgery only and had never been 
seen in the outpatient clinic. This left 1725 patients 
in the study cohort, of whom 1371 (79%) were un-
der the exclusive care of the team at our centre and 
354 (21%) were under shared care with nonspecial-
ist cardiologists in private practice or local hospi-
tals. Within the study cohort, 912 of 1725 patients 
(53%) were male. The median age at first visit was 
26.4 (10.9–82.1) years. Only two patients were 
younger than 16 years at their first clinic visit, both 
referred for family screening. The majority of pa-
tients had defects of moderate or great complexity. 
The overall proportion of patients with mild, mod-
erate and great disease complexity did not signifi-
cantly change over time. Type and frequency of de-
fects are summarised in table 1 and the increase in 
patient numbers during the study period is illus-
trated in figure 1, panel A. The number of patients 
under follow-up increased from 827 to 1725 
(+109%) between the first and the second decade of 
the study period and from 379 to 1725 (+355%) 
from the first (1996–2000) to the last 5-year period 
(2011–2015) of the study. Changes in referral pat-
terns of selected important congenital heart defects 
during the study period are depicted in figure 1, 
panel B. The median age at last clinic visit was 32.5 
(16.0–88.6) years.
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Table 1: Type and frequency of congenital heart defects within the study cohort. 
Type of defect n (%) 
Simple defects n = 600 (35%)  
Isolated aortic valve disease 162 (9.4) 
Isolated mitral valve disease 41 (2.4) 
Small secundum type atrial septal defect 39 (2.3) 
Repaired secundum type atrial septal defect 85 (4.9) 
Repaired sinus venosus defect 16 (0.9) 
Small ventricular septal defect 51 (3.0) 
Repaired ventricular septal defect 52 (3.0) 
Small patent ductus arteriosus 14 (0.8) 
Isolated pulmonary valve stenosis 47 (2.7) 
Non-congenital heart disease* 59 (3.4) 
Left ventricular non-compaction 19 (1.1) 
Other defects of mild complexity 21 (1.2) 
Defects of moderate complexity n = 749 (43%)  
Sinus venosus defect 13 (0.8) 
Coarctation of the aorta 127 (7.4) 
Ebstein anomaly 38 (2.2) 
Infundibular pulmonary stenosis 28 (1.6) 
Atrioventricular septal defect 77 (4.5) 
Supravalvar aortic stenosis 11 (0.6) 
Subvalvar aortic stenosis 20 (1.2) 
Hypertrophic cardiomyopathy 16 (0.9) 
Repaired tetralogy of Fallot 164 (9.5) 
Repaired double outlet right ventricle 18 (1.0) 
Marfan syndrome and related disorders 50 (2.9) 
Shone’s complex† 19 (1.1) 
Other defects of moderate complexity 162 (9.4) 
Defects of great complexity n = 376 (22%)  
Repaired pulmonary atresia 28 (1.6) 
Cyanotic heart disease 31 (1.8) 
Eisenmenger syndrome 50 (2.9) 
Fontan procedure for univentricular heart 49 (2.8) 
Transposition of the great arteries - atrial switch operation 119 (6.9) 
Transposition of the great arteries - arterial switch operation 29 (1.7) 
Transposition of the great arteries - Rastelli repair 8 (0.5) 
Congenitally corrected transposition of the great arteries 26 (1.5) 
Common arterial trunk 10 (0.6) 
Other defects of great complexity 26 (1.5) 
* Mainly women with pregnancy and acquired heart disease and family screening of relatives. 
† Shone’s complex refers to a combination of left ventricular inflow- and outflow obstruction, typically involving supravalvar membranous 
mitral valve stenosis, parachute mitral valve, subaortic stenosis, bicuspid aortic valve and aortic coarctation. 
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Figure 1: Evolution of patient numbers during the study period (red bars represent the first and blue bars the second decade of 
the study period). Panel A: Numbers of patients at the end of each 5-year era of the study period. Panel B: Comparison of newly 
referred patients with selected congenital heart defects, between the first and second decade of the study period.  
dTGA = d-transposition of the great arteries 
 
 
 
Figure 2: Increase in number of selected procedures between the first and the second decade of the study period. 
 
Evolution of cardiac surgery and percutaneous 
interventions during the study period 
During the 20-year study period, 432 of 1725 pa-
tients (25%) had at least one cardiac surgical proce-
dure at our institution and 115 patients (7%) had 
more than one and up to five surgical procedures. 
The total number of heart operations was 601, and 
183 of the operations using cardiopulmonary bypass 
were redo-surgery. The number of surgical proce-
dures within the first decade of the study period was 
264, compared with 335 within the second decade 
of the study period, an increase of 27%. 
The increase in percutaneous interventions was 
even more pronounced. During the study period, 
233 patients (14%) had at least one percutaneous in-
tervention and 47 patients (3%) had more than one 
and up to five interventions. The number of percu-
taneous interventions increased from 84 procedures 
within the first decade of the study period to 218 
procedures within the second decade of the study 
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period, an increase of 159%. The most common 
procedures were electrophysiological studies / ra-
diofrequency ablations (128 procedures), device 
closure of atrial septal defects (51 procedures), co-
arctation stenting (29 procedures) and percutaneous 
pulmonary valve implantation (27 procedures). The 
increase among these frequent procedures during 
the study period is illustrated in figure 2. 
Evolution of cardiac outpatient visits, morbidity 
and mortality during the study period 
The number of outpatient visits increased constantly 
during the study period, as depicted in figure 3. 
 
 
 
Figure 3: Number of outpatient visits during the study period. Panel A: Number of outpatient visits per 5-year intervals. Panel B: 
Number of outpatient visits per year over the last 5 years of the study period. 
 
While the number of patients under care increased 
by 109% from 2005 to 2015, the number of outpa-
tient visits increased by 195%. Of patients seen 
within the last 5 years of the study period, 68% had 
moderate or great disease complexity, which re-
flects the disease complexity within the entire study 
cohort (65% of patients with lesions of moderate or 
great complexity). During the study period, follow-
up policy and frequency of follow-up visits for the 
different congenital heart defects had not changed at 
our centre and followed recommended guidelines. 
The reason for the increasing numbers of outpatient 
visits are mainly increasing numbers of patients un-
der follow-up, as illustrated in figure 1, as well as 
increasing numbers of unplanned and emergency 
visits. This is indirectly illustrated by an increasing 
proportion of patients requiring electrical cardiover-
sion and patients suffering from infective endocar-
ditis (see next paragraph). 
A total of 92 patients (5%) died or underwent heart 
transplantation during the study period. Median age 
at death or transplantation was 42.9 (17.4–88.6) 
years. The median age at death remained unchanged 
over the study period. The number of patients who 
died more than doubled between the first decade of 
the study period (29 deaths) and the second decade 
(63 deaths). The majority of patients died from their 
cardiac disease. Of those for whom the cause of 
death was known (83%), sudden death (39%), heart 
failure (17%) and perioperative death (12%) were 
the most common causes. Among patients who died 
during the study period, 53% had defects of great, 
27% of moderate and 20% of simple complexity. 
Among deceased patients, those with a diagnosis of 
Eisenmenger syndrome (16%), atrial switch opera-
tions for transposition of the great arteries (12%), 
unrepaired cyanotic defects (9%) and patients with 
repaired tetralogy of Fallot (9%) contributed most 
to the overall mortality burden. Among individual 
disease entities, mortality was highest in patients 
with Eisenmenger syndrome (30%), followed by 
unrepaired cyanotic defects (26%), patients with 
congenitally corrected transposition of the great ar-
teries (19%), patients after atrial switch operations 
(9%), Fontan palliation (6%) and repaired tetralogy 
of Fallot (5%). 
Figure 4 depicts the number of direct current cardi-
oversions, the number of admissions for infective 
endocarditis and the number of women followed 
during pregnancy during the study period, which act 
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as surrogates for the increasing morbidity and com-
plexity among adults within our cohort. The major-
ity of women followed up during pregnancy were 
patients with repaired congenital heart defects 
(94%); a few had cardiomyopathy or acquired val-
var heart disease. 
 
 
Figure 4: Number of direct current cardioversions (panel A), 
number of admissions for infective endocarditis (panel B) and 
number of women followed during pregnancy (panel C). 
 
Within the first decade of the study period, 3.1% of 
patients under follow-up required a cardioversion 
versus 5.4% of patients in the second decade, a rel-
ative increase of 74%. The frequency of patients 
with infective endocarditis increased from 1.1% 
within the first decade to 1.7% in the second decade 
of the study period, a relative increase of 54%. 
Among patients suffering from infective endocardi-
tis, there was a trend towards higher disease com-
plexity compared with those without endocarditis 
(proportion of patients with defects of moder-
ate/great complexity 81% in the group with endo-
carditis vs 65% in those without endocarditis, p = 
0.061). Patients requiring electrical cardioversion 
had lesions of moderate/great disease complexity 
more frequently than those not requiring electrical 
cardioversion (82% vs 65%, p = 0.01). There was 
no difference in distribution of disease complexity 
among women followed up during a pregnancy 
(proportion of patients with defects of moder-
ate/great complexity 58% in the group of pregnant 
women vs 66% of those without pregnancy, p = 
0.12). 
Discussion 
As a result of successful surgical repair and pallia-
tion most patients born with congenital heart disease 
now survive to adulthood, and recent population-
based studies have shown a rapidly emerging and 
growing cohort of adults with congenital heart dis-
ease [4, 5]. After surgical repair, most patients go 
through a stable period, with a low risk of morbidity 
and mortality during childhood and adolescence 
[14]. These patients are, however, not cured. Many 
remain at substantially increased risk of cardiac 
morbidity and have an increased risk of premature 
death as young and middle-aged adults [6–8]. 
In this study we depicted the evolution of the adult 
patient population with congenital heart disease at a 
tertiary care centre over a 20-year period, and the 
impact of these growing patient numbers on work-
load for the multidisciplinary teams. The increasing 
workload is driven by both the increasing number of 
patients in follow-up and the increasing morbidity 
risks with the ageing of these cohorts, as illustrated 
by the increasing proportion of patients requiring 
cardioversion or suffering from infective endocardi-
tis. Previous work by Marelli and colleagues, 
providing population based data from Canada, has 
shown an increase in the prevalence of adults with 
congenital heart disease of 57% between the years 
2000 and 2010 [5]. During the same period, the 
number of patients followed up at our centre in-
creased by 186%, followed by an additional in-
crease of 59% during the subsequent 5 years be-
tween 2011 and 2015. This is important as it shows 
that the number of patients followed up at tertiary 
care centres increased more rapidly than the overall 
prevalence of adults with congenital heart disease. 
This probably reflects adherence to guideline rec-
ommendations that adults with congenital heart dis-
ease should be followed up by multidisciplinary 
teams at dedicated tertiary care centres [11–13]. Re-
cent studies have suggested improved outcomes for 
patients followed up at tertiary care centres [9, 10]. 
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Increasing morbidity and mortality 
A large proportion of patients in our cohort required 
surgical or interventional procedures during adult 
life; hence, the numbers of operations, and particu-
larly the number of percutaneous interventions, 
steadily increased. This underscores the notion that 
many adults with repaired congenital heart defects 
have important residual lesions requiring redo-inter-
ventions in adulthood. Particularly striking is the in-
creasing number of electrophysiological procedures 
and radiofrequency ablations, as well as the increas-
ing number of direct current cardioversions. This 
highlights the high prevalence of arrhythmias in 
adults with congenital heart disease, by far the most 
common cardiovascular complication in this patient 
group [7]. The number of patients within our cohort 
who died more than doubled between the first and 
the second decade of the study period. This is an im-
portant marker of increasing workload; because 
most patients who died had multiple previous hos-
pital admissions and, typically, intensive in- and 
outpatient care before their demise, these patients 
require a great deal of personnel and time resources 
[15]. Given that the majority of patients within our 
cohort were still young at the end of the study pe-
riod, it is likely that, with the ageing of these co-
horts, the number of young and middle-aged adults 
reaching the end stage of their disease will rapidly 
increase [8]. Heart failure was among the leading 
causes of death in our cohort. With ageing of the 
patient cohorts, heart failure will certainly become 
much more frequent and will substantially contrib-
ute to in- and outpatient workload. Heart transplan-
tation or advanced heart failure treatment (including 
ventricular assist devices) may be an option for 
some of these patients, but for many there will prob-
ably be no such option and end-of-life support for 
patients and their families will become an important 
part of specialist care [8, 16, 17]. Patients dying un-
der our care will thus substantially add to the overall 
workload of our in- and outpatient services. Given 
that most women survive to childbearing age, the 
number of women who embark on pregnancy is 
steadily increasing. Depending on the type of de-
fect, residual lesions and other individual disease 
characteristics, these women may be at increased 
risk for complications during pregnancy and require 
intensive counselling and follow-up during preg-
nancy, as well as in the peri- and postpartum periods 
[18]. 
There has been a rapid increase in hospital admis-
sions of patients with infective endocarditis. With 
the increasing number of patients who undergo im-
plantation of prosthetic heart valves, particularly in 
the pulmonary position, the cohort of patients suf-
fering from infective endocarditis will probably 
continue to further increase in the future [19]. 
Evolution of adult patient cohorts 
As expected, major differences in the evolution of 
cohorts with different types of congenital heart de-
fects was observed. As most cyanotic defects have 
been successfully repaired or palliated since the 
1980s, only few patients with unrepaired cyanotic 
defects entered the adult cohort after the year 2000. 
The same is true for patients with Eisenmenger syn-
drome, which is defined by irreversible pulmonary 
hypertension as the consequence of an unrepaired 
shunt lesion with eventual shunt reversal. As pa-
tients with shunt lesions are usually detected early 
in life and operated on in a timely manner, Eisen-
menger syndrome in young adults has become rare. 
This observation supports findings from previous 
studies [8]. 
Interestingly, the number of patients with Fontan 
palliation who entered the adult cohort was almost 
as high within the first decade of the study period as 
in the second decade. This is surprising, as the Fon-
tan palliation for univentricular hearts was first pro-
posed in the 1970s and widely introduced into the 
surgical armamentarium only in the 1980s. The high 
number of Fontan patients who entered the adult co-
hort at our institution before 2000 is probably a con-
sequence of the fact that the surgical programme at 
our institution was led by Professor Åke Senning, 
one of the pioneers in surgical repair of congenital 
heart disease, and thus the Fontan palliation was in-
troduced relatively early at our institution. 
As expected, patients with repaired transposition of 
the great arteries who entered the adult cohort 
within the second decade of the study period had 
mainly undergone arterial switch repair, which re-
placed the atrial switch repair (Senning or Mustard 
procedures) in the 1980s. The number of patients 
with repaired tetralogy of Fallot remained relatively 
unchanged between the first and the second decade 
of the study period. 
Limitations 
This was a retrospective analysis of patients identi-
fied from our clinical database. Patient with errone-
ous diagnostic coding may thus have been missed. 
We restricted our analysis to patients followed up 
by the dedicated multi-disciplinary team for adults 
with congenital heart disease at our institution. Pa-
tients followed up by general cardiologists within 
tertiary care centres may add to the overall burden 
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of patient care and further increase the need for re-
sources. Some of the fluctuations of patient num-
bers, number of procedures and outpatient visits 
may reflect changes in staff over the 20-year study 
period. 
Although the experience at our centre probably mir-
rors the experience at other tertiary care centres, dif-
ferent referral patterns and different organisation of 
care will inevitably lead to differences in the evolu-
tion of patient cohorts. 
Conclusions 
The increasing number of adult survivors with con-
genital heart disease leads to an over-proportional 
increase in patients followed at dedicated tertiary 
care centres. These patients are not cured, have a 
high risk of cardiovascular complications, many re-
quire redo-surgery or interventions and many have 
an increased risk of premature death. There is and 
will be a rapidly increasing need for more resources 
to cope with the increasing workload for this new 
cohort of complex patients in adult cardiology. Our 
data may help healthcare authorities and hospital 
administrations to allocate appropriate resources. 
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